Pattern of clopidogrel use in hospitalized patients receiving percutaneous coronary interventions

American Journal of Health-System Pharmacy

Volumn 67, Issue 17, 2010, Pages 1430-1437

  Dean, Bonnie B ^a   Yu, Hsing Ting ^a   Bae, Jay P ^b   Fiske, Suzanne ^a   Meadows, Eric ^b   Xiong, Yan ^a   Emons, Matthew F ^a  

^a CERNER CORPORATION   (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

Acute coronary syndrome; Angina; Angioplasty; Clopidogrel; Dosage; Drug use; Hospitals; Myocardial infarction; Platelet aggregation inhibitors; Protocols

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PROTAMINE SULFATE; DRUG DERIVATIVE; TICLOPIDINE;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; BOLUS INJECTION; CORONARY STENT; DRUG USE; ELECTIVE SURGERY; ELECTRONIC MEDICAL RECORD; FEMALE; HOSPITAL PATIENT; HUMAN; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; PREMEDICATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TREATMENT INDICATION; UNITED STATES; UNSTABLE ANGINA PECTORIS; ANGINA PECTORIS; DRUG UTILIZATION; HEART INFARCTION; HOSPITALIZATION; MIDDLE AGED; PERIOPERATIVE PERIOD; TRANSLUMINAL CORONARY ANGIOPLASTY;

ACUTE CORONARY SYNDROME; ADULT; AGED; AGED, 80 AND OVER; ANGINA PECTORIS; ANGIOPLASTY, BALLOON, CORONARY; DRUG UTILIZATION; ELECTRONIC HEALTH RECORDS; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERIOPERATIVE PERIOD; PLATELET AGGREGATION INHIBITORS; PRACTICE GUIDELINES AS TOPIC; RETROSPECTIVE STUDIES; TICLOPIDINE; UNITED STATES;

EID: 79952020973     PISSN: 10792082     EISSN: 15352900     Source Type: Journal    
DOI: 10.2146/ajhp100008     Document Type: Article

References (27)

1. American Heart Association. Heart disease and stroke statistics - 2009 update. Dallas, TX: American Heart Association; 2009.
2. Levine GN, Kern MJ, Berger PB et al. Management of patients undergoing percutaneous coronary revascularization. Ann Intern Med. 2003; 139:123-36.
3. Plavix prescribing information. http://products.sanofi-aventis.us/plavix/ plavix.html (accessed 2009 May 8).
4. Hochholzer W, Trenk D, Frundi D et al. Time dependence of platelet inhibition after a 600-mg loading dose of clopidogrel in a large, unselected cohort of candidates for percutaneous coronary intervention. Circulation. 2005; 111:2560-4. (Pubitemid 40740853)
5. Abuzahra M, Pillai M, Caldera A et al. Comparison of higher clopidogrel loading and maintenance dose to standard dose on platelet function and outcomes after percutaneous coronary intervention using drug-eluting stents. Am J Cardiol. 2008; 102:401-3.
6. Lotrionte M, Biondi-Zoccai GG, Agostoni P et al. Meta-analysis appraising high clopidogrel loading in patients undergoing percutaneous coronary intervention. Am J Cardiol. 2007; 100:1199-206.
7. Price MJ, Coleman JL, Steinhubl SR et al. Onset and offset of platelet inhibition after high-dose clopidogrel loading and standard daily therapy measured by a point-of-care assay in healthy volunteers. Am J Cardiol. 2006; 98:681-4. (Pubitemid 44233472)
8. Steinhubl SR, Berger PB, Mann JT III et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA. 2002; 288:2411-20. (Pubitemid 35340537)
9. Lev EI, Kornowski R, Vaknin-Assa H et al. Effect of clopidogrel pretreatment on angiographic and clinical outcomes in patients undergoing primary percutaneous coronary intervention for ST-elevation acute myocardial infarction. Am J Cardiol. 2008; 101:435-9. (Pubitemid 351199431)
10. Steinhubl SR, Berger PB, Brennan DM et al. Optimal timing for the initiation of pre-treatment with 300 mg clopidogrel before percutaneous coronary intervention. J Am Coll Cardiol. 2006; 47:939-43.
11. Szuk T, Gyongyosi M, Homorodi N et al. Effect of timing of clopidogrel administration on 30-day clinical outcomes: 300-mg loading dose immediately after coronary stenting versus pretreatment 6 to 24 hours before stenting in a large unselected patient cohort. Am Heart J. 2007; 153:289-95. (Pubitemid 46096860)
12. Gurbel PA, Cummings CC, Bell CR et al. Onset and extent of platelet inhibition by clopidogrel loading in patients undergoing elective coronary stenting: the Plavix Reduction Of New Thrombus Occurrence (PRONTO) trial. Am Heart J. 2003; 145:239-47. (Pubitemid 36207944)
13. Kushner FG, Hand M, Smith SC Jr et al. 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2009; 120:2271-306.
14. Bradley EH, Nallamothu BK, Herrin J et al. National efforts to improve door-to-balloon time results from the Door-to-Balloon Alliance. J Am Coll Cardiol. 2009; 54:2423-9.
15. U.S. Department of Health and Human Services, Office for Civil Rights. HIPAA medical privacy - national standards to protect the privacy of personal health information. https://www.cms.gov/HIPAAGenInfo/Downloads/HIPAALaw.pdf (accessed 2010 Jun 23).
16. Bates ER, Lau WC, Bleske BE. Loading, pretreatment, and interindividual variability issues with clopidogrel dosing. Circulation. 2005; 111:2557-9. (Pubitemid 40740852)
17. Mehta SR, Bassand JP, Chrolavicius S et al. Design and rationale of CURRENT-OASIS 7: a randomized, 2 x 2 factorial trial evaluating optimal dosing strategies for clopidogrel and aspirin in patients with ST and non-ST-elevation acute coronary syndromes managed with an early invasive strategy. Am Heart J. 2008; 156:1080-8.
18. Double doses of clopidogrel better than standard doses for heart patients undergoing angioplasty, an international study finds. European Society of Cardiology Congress 2009. www.escardio.org/about/press/press-releases/esc09- barcelona/Pages/esc-2009-Mehta-Current%20Oasis%207.aspx (accessed 2010 Mar 16).
19. Anderson JL, Adams CD, Antman EM et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. Circulation. 2007; 116:e148-304.
20. Giugliano RP, White JA, Bode C et al. Early versus delayed, provisional eptifibatide in acute coronary syndromes. N Engl J Med. 2009; 360:2176-90.
21. Ziegler S, Schillinger M, Funk M et al. Association of a functional polymorphism in the clopidogrel target receptor gene, P2Y12, and the risk for ischemic cerebrovascular events in patients with peripheral artery disease. Stroke. 2005; 36:1394-9.
22. Maree AO, Fitzgerald DJ. Variable platelet response to aspirin and clopidogrel in atherothrombotic disease. Circulation. 2007; 115:2196-207. (Pubitemid 46659072)
23. Plavix prescribing information. sanofi-aventis. http://products.sanofi- aventis.us/PLAVIX/PLAVIX.html (accessed 2010 Mar 19).
24. Gilard M, Arnaud B, Cornily JC et al. Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study. J Am Coll Cardiol. 2008; 51:256-60.
25. Ho PM, Maddox TM, Wang L et al. Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome. JAMA. 2009; 301:937-44.
26. O'Donoghue ML, Braunwald E, Antman EM et al. Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials. Lancet. 2009; 374:989-97.
27. CathPCI Registry. NCDR Cath PCI Registry v4.3.1 coder's data dictionary. www.ncdr.com/WebNCDR/NCDRDocuments/CathPCI-v4-CodersDictionary-4.3.1.pdf (accessed 2010 Mar 16).